On May 2, 2024, Laizer Kornwasser, President of Enterprise Growth at Teladoc Health Inc (NYSE:TDOC), sold 10,411 shares of the company. The transaction was filed on the same day with the SEC.
Teladoc Health Inc (NYSE:TDOC) is a telehealth and virtual healthcare company providing services such as telemedicine, medical opinions, AI and analytics, and licensable platform services. The company operates globally, offering solutions that enable patients to access healthcare services remotely.
The shares were sold at a price of $12.69 each, resulting in a total transaction amount of approximately $132,192. This sale by the insider is part of a broader trend observed over the past year, where Teladoc Health Inc has seen a total of 73 insider sells and no insider buys. Over the past year, Laizer Kornwasser has sold a total of 54,180 shares of the company.
As of the latest sale, Teladoc Health Inc has a market cap of approximately $2.20 billion. The stock’s valuation metrics show a GF Value of $31.89, indicating a price-to-GF-Value ratio of 0.4. This suggests that the stock is currently undervalued, classified as a “Possible Value Trap, Think Twice” according to GuruFocus analysis.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This recent insider transaction provides investors with insight into the actions of key executives at Teladoc Health Inc, reflecting their transactions and potentially their perspective on the stock’s current valuation.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
